“BioLineRx Ltd. ( BLRXBioLineRx Ltd. BLRX1.97 -0.01 (-0.51%)Powered by Market IQ ), a clinical-stage biopharmaceutical company, reported positive pre-clinical results for BL-9020, a novel monoclonal antibody for the treatment of Type 1 diabetes. The results were published on-line in PLoS One.”

frothmouth のブックマーク 2015/03/14 23:32

<blockquote class="hatena-bookmark-comment"><a class="comment-info" href="https://b.hatena.ne.jp/entry/244473615/comment/frothmouth" data-user-id="frothmouth" data-entry-url="https://b.hatena.ne.jp/entry/s/www.nasdaq.com/article/biolinerx-reports-positive-preclinical-results-for-bl9020-in-type-1-diabetes-20150311-00195" data-original-href="https://www.nasdaq.com/article/biolinerx-reports-positive-preclinical-results-for-bl9020-in-type-1-diabetes-20150311-00195" data-entry-favicon="https://cdn-ak2.favicon.st-hatena.com/64?url=https%3A%2F%2Fwww.nasdaq.com%2Farticle%2Fbiolinerx-reports-positive-preclinical-results-for-bl9020-in-type-1-diabetes-20150311-00195" data-user-icon="/users/frothmouth/profile.png">SMART Modular Announces NVDIMMs with Encryption for High Security Applications</a><br><p style="clear: left">“BioLineRx Ltd. ( BLRXBioLineRx Ltd. BLRX1.97 -0.01 (-0.51%)Powered by Market IQ ), a clinical-stage biopharmaceutical company, reported positive pre-clinical results for BL-9020, a novel monoclonal antibody for the treatment of Type 1 diabetes. The results were published on-line in PLoS One.”</p><a class="datetime" href="https://b.hatena.ne.jp/frothmouth/20150314#bookmark-244473615"><span class="datetime-body">2015/03/14 23:32</span></a></blockquote><script src="https://b.st-hatena.com/js/comment-widget.js" charset="utf-8" async></script>

このブックマークにはスターがありません。
最初のスターをつけてみよう！

SMART Modular Announces NVDIMMs with Encryption for High Security Applications

www.nasdaq.com2015/03/14

1 人がブックマーク・1 件のコメント

他のコメントを読む

＼コメントがサクサク読めるアプリです／

はてなブックマーク

SMART Modular Announces NVDIMMs with Encryption for High Security Applications

はてなブックマーク

公式Twitter

はてなのサービス